Cure8 research brief
Cure8 research brief
Anemia is a common and persistent extraintestinal complication of IBD that can affect quality of life and may require monitoring and treatment. Knowing how common it remains years after diagnosis helps patients and clinicians plan follow-up and screening.
Adults with Crohn’s disease or ulcerative colitis; newly diagnosed patients; clinicians who monitor or treat IBD complications; researchers studying IBD comorbidities.
This study used a large hospital registry (Helsinki University Hospital) spanning 2000–2025 to measure how common anemia is in adults with IBD (both Crohn’s disease and ulcerative colitis). Among 3,698 patients, anemia was very common at the year of diagnosis and remained present in a substantial minority up to 5 years later.
The analysis found higher anemia prevalence in patients with more complex disease phenotypes, and a notable sex difference (higher percentages reported in women). Prevalence declined over time after diagnosis and was lower for patients diagnosed after 2010 compared with those diagnosed earlier.
These results summarize prevalence and associations from registry data and do not test a treatment or an intervention.
Findings come from a retrospective registry at a single Finnish university hospital covering 2000–2025; results describe prevalence and associations but do not evaluate treatments. Reported declines over calendar time may reflect changes in care or diagnosis practices.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.